Brief: Procept Biorobotics Q2 Basic EPS USD -0.5
01/08/2024 21:03
Aug 01 (Reuters) - Procept Biorobotics Q2 revenue USD 53.353 million vs. IBES estimate USD 50.2 million. * Q2 gross profit USD 31.482 million * Q2 operating income USD -26.828 million vs. IBES estimate USD -28.8 million * Q2 net income USD -25.626 million vs. IBES estimate USD -26.9 million * Q2 adjusted EBITDA USD -17.93 million vs. IBES estimate USD -20.1 million * outlook FY revenue USD 217 million * outlook FY gross margin 59%
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc